HEOVX | RWIEX | HEOVX / RWIEX | |
Total Expense Ratio | 0.69 | 0.76 | 91% |
Annual Report Gross Expense Ratio | 0.80 | 0.76 | 105% |
Fund Existence | 9 years | 23 years | - |
Gain YTD | 0.900 | 0.900 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116M | 123B | 0% |
Annual Yield % from dividends | 0.83 | 1.63 | 51% |
Returns for 1 year | 1.81 | 3.38 | 53% |
Returns for 3 years | 14.57 | 23.25 | 63% |
Returns for 5 years | 74.04 | 52.17 | 142% |
Returns for 10 years | N/A | 38.98 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBC | 19.09 | 0.40 | +2.14% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
AEF | 5.17 | 0.02 | +0.39% |
abrdn Emerging Markets ex-China Fund Inc. | |||
BOND | 92.03 | -0.06 | -0.07% |
PIMCO Active Bond ETF | |||
RAYD | 32.85 | -0.04 | -0.12% |
Rayliant Quantitative Dev Mkt Eq ETF | |||
IBDY | 25.49 | -0.04 | -0.16% |
iShares iBonds Dec 2033 Term Corp ETF |